{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:16Z","timestamp":1792143856827,"version":"4.4.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ejhf\/xuag306","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:26:14Z","timestamp":1791113174000},"source":"Crossref","is-referenced-by-count":0,"title":["Digitoxin\u2014first choice cardiac glycoside for heart failure with reduced ejection fraction"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-117X","authenticated-orcid":false,"given":"Johann","family":"Bauersachs","sequence":"first","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2514","authenticated-orcid":false,"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine) and Klinik f\u00fcr Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Saarland University , Homburg\/Saar ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-6739","authenticated-orcid":false,"given":"Gerhard","family":"Poelzl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Cardiology and Angiology, Medical University Innsbruck , Innsbruck, Tyrol 6020 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-7314","authenticated-orcid":false,"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) of German Heart Center Charit\u00e9, German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-2571","authenticated-orcid":false,"given":"Udo","family":"Bavendiek","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"2026101604465262100_xuag306-B1","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1093\/eurheartj\/ehad185","article-title":"Digitalis in heart failure: declining use and ongoing outcome trials","volume":"44","author":"van Veldhuisen","year":"2023","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/1050-1738(92)90040-Y","article-title":"Digitalis and baroreflexes in heart failure","volume":"2","author":"Ferguson","year":"1992","journal-title":"Trends Cardiovasc Med"},{"key":"2026101604465262100_xuag306-B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0735-1097(89)90561-5","article-title":"Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure","volume":"13","author":"Gheorghiade","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2026101604465262100_xuag306-B4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/0735-1097(93)90579-p","article-title":"Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)","volume":"22","author":"van Veldhuisen","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2026101604465262100_xuag306-B5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2026101604465262100_xuag306-B6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/eurheartj\/ehs004","article-title":"Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure","volume":"33","author":"Castagno","year":"2012","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","article-title":"Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial","volume":"15","author":"Gheorghiade","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B9","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1093\/eurheartj\/ehag100","article-title":"2026 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"47","author":"Kober","year":"2026","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B10","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ejhf.3428","article-title":"Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial","volume":"26","author":"van Veldhuisen","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B11","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1038\/s41591-026-04406-6","article-title":"Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial","volume":"32","author":"van Veldhuisen","year":"2026","journal-title":"Nat Med"},{"key":"2026101604465262100_xuag306-B12","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/ejhf.3679","article-title":"DIGitoxin to improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): baseline characteristics compared to recent randomized controlled heart failure trials","volume":"27","author":"Bavendiek","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B13","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2415471","article-title":"Digitoxin in patients with heart failure and reduced ejection fraction","volume":"393","author":"Bavendiek","year":"2025","journal-title":"N Engl J Med"},{"key":"2026101604465262100_xuag306-B14","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuag275","article-title":"Efficacy of digitoxin over time in patients with heart failure and reduced ejection fraction: further analysis of DIGIT-HF","author":"Bavendiek","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag387","article-title":"Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trials","author":"Helseth","year":"2026","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B16","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1093\/eurheartj\/ehag379","article-title":"Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial","volume":"47","author":"Bavendiek","year":"2026","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B17","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1093\/eurheartj\/ehag385","article-title":"Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial","volume":"47","author":"van der Meer","year":"2026","journal-title":"Eur Heart J"},{"key":"2026101604465262100_xuag306-B18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0735-1097(93)90403-n","article-title":"Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED investigative group","volume":"22","author":"Uretsky","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2026101604465262100_xuag306-B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE study","volume":"329","author":"Packer","year":"1993","journal-title":"N Engl J Med"},{"key":"2026101604465262100_xuag306-B20","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2026.7886","article-title":"Efficacy and safety of Digitalis glycosides in heart failure: a meta-analysis","volume":"335","author":"Damman","year":"2026","journal-title":"JAMA"},{"key":"2026101604465262100_xuag306-B21","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuag281","article-title":"Artificial intelligence predicted ESC 2026 heart failure guidelines","author":"Baudry","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ejhf\/xuaf002","article-title":"Bavendiek U Digitalis\u2014back on centre stage for HFrEF","volume":"28","author":"Bauersachs","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"2026101604465262100_xuag306-B23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00392-023-02199-z","article-title":"Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial","volume":"112","author":"Bavendiek","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2026101604465262100_xuag306-B24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4081\/cardio.2026.117","article-title":"2026 iCARDIO alliance global implementation guidelines on heart failure","volume":"4","author":"Chopra","year":"2026","journal-title":"Global Cardiology"},{"key":"2026101604465262100_xuag306-B25","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuag270","article-title":"Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States","author":"Boettger","year":"2026","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag306\/71626913\/xuag306.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag306\/71626913\/xuag306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:46:56Z","timestamp":1792140416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag306\/8868940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag306","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"xuag306"}}